| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 91.58B | 98.72B | 103.88B | 96.93B | 81.73B |
| Gross Profit | 24.52B | 27.37B | 26.34B | 24.47B | 23.27B |
| EBITDA | 12.38B | 14.61B | 14.78B | 11.54B | 13.82B |
| Net Income | 3.93B | 6.47B | 6.39B | 4.47B | 7.33B |
Balance Sheet | |||||
| Total Assets | 106.42B | 119.41B | 111.90B | 110.92B | 99.63B |
| Cash, Cash Equivalents and Short-Term Investments | 9.47B | 11.09B | 13.32B | 11.22B | 13.66B |
| Total Debt | 15.34B | 20.04B | 21.69B | 21.27B | 19.21B |
| Total Liabilities | 50.75B | 57.44B | 56.95B | 56.88B | 54.26B |
| Stockholders Equity | 53.56B | 59.65B | 52.74B | 51.93B | 43.65B |
Cash Flow | |||||
| Free Cash Flow | 4.28B | 5.11B | 8.02B | 428.00M | 1.36B |
| Operating Cash Flow | 7.89B | 10.79B | 13.78B | 5.64B | 5.25B |
| Investing Cash Flow | -1.50B | -5.60B | -5.87B | -5.35B | -3.15B |
| Financing Cash Flow | -8.29B | -7.57B | -4.51B | -3.40B | -3.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $16.34B | 61.17 | 8.66% | ― | 8.27% | 19.06% | |
78 Outperform | $19.91B | 19.95 | 17.96% | 2.52% | 0.24% | -1.85% | |
77 Outperform | $15.73B | 30.63 | 38.11% | 1.22% | 3.27% | 10.89% | |
69 Neutral | $6.90B | 24.09 | 9.60% | 1.61% | -1.01% | -12.13% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | $13.11B | 31.98 | 4.52% | 4.42% | -1.40% | ― | |
61 Neutral | $12.23B | 30.68 | 8.42% | 2.98% | -0.39% | -11.34% |